In a more recent study, Sanchez et al.[60] have reported their observations on exposure of ECs to some of the newer MM induction chemotherapy agents and they have shown that these agents can in fact lead to increased VWF and ICAM-1 expression and also an increase in cell permeability, exhibited by reduced VE-cadherin expression and cell monolayer integrity. Here, VWF is linked to Miyoshi myopathy.